74838JAA9
Quidelortho Corp
Could not find a ticker for this position, may be a filing error
A maker of medical diagnostic tests, QuidelOrtho supplies the rapid tests and lab analyzers doctors, hospitals, and blood banks use to spot illness and match blood types. It was born in 2022 when two companies merged: Quidel, founded in San Diego in 1979, and Ortho Clinical Diagnostics, whose roots reach back to 1939 as a Johnson & Johnson division that helped pioneer safe blood transfusions. Its Sofia analyzer—named for its fluorescent rapid-testing system—won a Good Design award for its small, user-friendly design.
CONVERTIBLEUnderlying: QDELCUSIP: 74838JAA9HealthcareUS1 derivative reporter
3.25% Convertible Bond due 12/15/2020
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
